Search Results - "Marcus, Julia"

Refine Results
  1. 1

    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics Should Inform Policy by Cevik, Muge, Marcus, Julia L, Buckee, Caroline, Smith, Tara C

    Published in Clinical infectious diseases (01-08-2021)
    “…Abstract It is generally agreed that striking a balance between resuming economic and social activities and keeping the effective reproductive number (R0)…”
    Get full text
    Journal Article
  2. 2

    Free the PrEP — Over-the-Counter Access to HIV Preexposure Prophylaxis by Krakower, Douglas, Marcus, Julia L.

    Published in The New England journal of medicine (10-08-2023)
    “…Several barriers to access to preexposure prophylaxis for HIV could be alleviated by making it available over the counter. This step could particularly…”
    Get full text
    Journal Article
  3. 3

    No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting by Volk, Jonathan E., Marcus, Julia L., Phengrasamy, Tony, Blechinger, Derek, Nguyen, Dong Phuong, Follansbee, Stephen, Hare, C. Bradley

    Published in Clinical infectious diseases (15-11-2015)
    “…Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical…”
    Get full text
    Journal Article
  4. 4

    No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis by Marcus, Julia L, Glidden, David V, Mayer, Kenneth H, Liu, Albert Y, Buchbinder, Susan P, Amico, K Rivet, McMahan, Vanessa, Kallas, Esper Georges, Montoya-Herrera, Orlando, Pilotto, Jose, Grant, Robert M

    Published in PloS one (18-12-2013)
    “…Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex…”
    Get full text
    Journal Article
  5. 5

    Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation by Marcus, Julia L, Hurley, Leo B, Hare, Charles Bradley, Nguyen, Dong Phuong, Phengrasamy, Tony, Silverberg, Michael J, Stoltey, Juliet E, Volk, Jonathan E

    “…BACKGROUND:Placebo-controlled and open-label studies have demonstrated the safety and efficacy of daily oral preexposure prophylaxis (PrEP) in preventing HIV…”
    Get full text
    Journal Article
  6. 6

    Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infections by Mayer, Kenneth H, Traeger, Michael, Marcus, Julia L

    “…This JAMA Insights discusses the use of antibiotics for sexually transmitted infection prevention…”
    Get full text
    Journal Article
  7. 7

    Perverse Incentives — HIV Prevention and the 340B Drug Pricing Program by Marcus, Julia L., Killelea, Amy, Krakower, Douglas S.

    Published in The New England journal of medicine (02-06-2022)
    “…A decade after preexposure prophylaxis against HIV became available, less than a quarter of people in the United States who could benefit from PrEP are taking…”
    Get full text
    Journal Article
  8. 8

    Words Matter: Putting an End to “Unsafe” and “Risky” Sex by Marcus, Julia L., Snowden, Jonathan M.

    Published in Sexually transmitted diseases (01-01-2020)
    “…Change is constant in sexual health, as in health care more broadly. Novel pathogens are identified, epidemics emerge and reemerge, and new preventive and…”
    Get full text
    Journal Article
  9. 9

    Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care by Marcus, Julia L, Chao, Chun R, Leyden, Wendy A, Xu, Lanfang, Quesenberry, Charles P, Klein, Daniel B, Towner, William J, Horberg, Michael A, Silverberg, Michael J

    “…BACKGROUND:It is unknown if a survival gap remains between HIV-infected and HIV-uninfected individuals with access to care. METHODS:We conducted a cohort study…”
    Get full text
    Journal Article
  10. 10

    Projected HIV and Bacterial Sexually Transmitted Infection Incidence Following COVID-19–Related Sexual Distancing and Clinical Service Interruption by Jenness, Samuel M, Le Guillou, Adrien, Chandra, Christina, Mann, Laura M, Sanchez, Travis, Westreich, Daniel, Marcus, Julia L

    Published in The Journal of infectious diseases (29-03-2021)
    “…Abstract Background The global COVID-19 pandemic has the potential to indirectly impact transmission dynamics and prevention of HIV and other sexually…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Intervention treatment distributions that depend on the observed treatment process and model double robustness in causal survival analysis by Wen, Lan, Marcus, Julia L., Young, Jessica G.

    Published in Statistical methods in medical research (01-03-2023)
    “…The generalized g-formula can be used to estimate the probability of survival under a sustained treatment strategy. When treatment strategies are…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value? by Krakower, Douglas S, Daskalakis, Demetre C, Feinberg, Judith, Marcus, Julia L

    Published in Annals of internal medicine (18-02-2020)
    “…Krakower et al examine the use of tenofovir alafenamide for HIV preexposure prophylaxis. In early 2019, the US government launched the Ending the HIV Epidemic…”
    Get full text
    Journal Article
  15. 15

    Risk Compensation and Clinical Decision Making — The Case of HIV Preexposure Prophylaxis by Marcus, Julia L, Katz, Kenneth A, Krakower, Douglas S, Calabrese, Sarah K

    Published in The New England journal of medicine (07-02-2019)
    “…Uptake of preexposure prophylaxis (PrEP) for HIV has been limited for multiple reasons, including low awareness. Clinicians’ concerns that an increased sense…”
    Get full text
    Journal Article
  16. 16

    HIV pre-exposure prophylaxis provision by U.S. health centers in 2021 by Chinbunchorn, Tanat, Mayer, Kenneth H, Campbell, Juwan, King, Dana, Krakower, Douglas, Marcus, Julia L, Grasso, Chris, Keuroghlian, Alex S

    Published in AIDS (London) (01-03-2024)
    “…The aim of this study was to assess HIV preexposure prophylaxis (PrEP) provision in U.S. health centers. The U.S. Ending the HIV Epidemic (EHE) initiative…”
    Get full text
    Journal Article
  17. 17

    Potential impact of doxycycline post-exposure prophylaxis prescribing strategies on incidence of bacterial sexually transmitted infections by Traeger, Michael W, Mayer, Kenneth H, Krakower, Douglas S, Gitin, Sy, Jenness, Samuel M, Marcus, Julia L

    Published in Clinical infectious diseases (18-08-2023)
    “…Doxycycline post-exposure prophylaxis (doxyPEP) reduces bacterial sexually transmitted infection (STI) incidence in people with HIV (PWH) or using HIV…”
    Get full text
    Journal Article
  18. 18

    Artificial Intelligence and Machine Learning for HIV Prevention: Emerging Approaches to Ending the Epidemic by Marcus, Julia L., Sewell, Whitney C., Balzer, Laura B., Krakower, Douglas S.

    Published in Current HIV/AIDS reports (01-06-2020)
    “…Purpose of Review We review applications of artificial intelligence (AI), including machine learning (ML), in the field of HIV prevention. Recent Findings ML…”
    Get full text
    Journal Article
  19. 19
  20. 20